Q&A: Vaccine Emergency Use Around the Corner for Children 5 to 11
With data from a pivotal Pfizer-BioNTech study (under review by the FDA) showing robust antibody responses in children ages 5 to 11, UVA Today spoke with expert Dr. William Petri about child vaccinations.